Related Experiment Video
Updated: May 18, 2026
04:40
Venous Thrombosis Assay in a Mouse Model of Cancer
Published on: January 5, 2024
Thrombosis in myeloma treated with IMiDs
1Service des Maladies du Sang, Hôpital Huriez, CHRU, Lille France. xavier.leleu@chru-lille.fr
Thrombosis Research
|October 3, 2012
Summary
Novel agents improve multiple myeloma survival but increase risks of blood clots. Prophylactic treatment is now essential, yet optimal strategies and risk factors require further investigation.
Area of Science:
- Hematology
- Oncology
- Pharmacology
Background:
- Novel agents, particularly immunomodulatory drugs (IMiDs), have significantly improved multiple myeloma patient survival.
- A major concern is the concurrent rise in venous and arterial thromboembolic events associated with IMiD therapy.
Purpose of the Study:
- To address the critical need for optimal thromboprophylaxis in multiple myeloma patients treated with IMiDs.
- To highlight remaining questions regarding the choice of prophylactic treatment and identification of risk factors.
Main Methods:
- Review of current literature and guidelines on thromboprophylaxis in multiple myeloma.
- Analysis of the incidence and risk factors for thromboembolic events in patients receiving IMiDs.
Main Results:
- While survival has improved, thromboembolic events pose a significant challenge.
- Existing guidelines for thromboprophylaxis are insufficient, with unresolved questions on optimal agent selection and risk stratification.
Conclusions:
- Thromboprophylaxis is mandatory for multiple myeloma patients on IMiDs.
- Further research is essential to define optimal thromboprophylaxis strategies and identify high-risk patients.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...